| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 347,4 M € | +3.4% | 335,9 M € | +4.0% | 322,9 M € | +13.6% | 284,3 M € | +3.1% | 275,8 M € | +0.9% | 273,3 M € | +4.9% | 260,5 M € | +6.7% | 244,1 M € | +1.0% | 241,7 M € | +1.6% | 238,0 M € | +7.4% | 221,6 M € | -1.8% | 225,6 M € | +8.3% | 208,3 M € | +27.8% | 163,0 M € | +26.9% | 128,4 M € | +5.3% | 122,0 M € | +7.7% | 113,3 M € | |
| EBITDA | 23,9 M € | +16.3% | 20,6 M € | +12.2% | 18,3 M € | -11.3% | 20,7 M € | -0.7% | 20,8 M € | -18.5% | 25,5 M € | +22.0% | 20,9 M € | +44.8% | 14,5 M € | -11.2% | 16,3 M € | -0.6% | 16,4 M € | -8.5% | 17,9 M € | +8.4% | 16,5 M € | -18.7% | 20,3 M € | +64.4% | 12,4 M € | +38.2% | 8,9 M € | -4.8% | 9,4 M € | -23.4% | 12,3 M € | |
| Operating profit | 22,0 M € | +22.3% | 18,0 M € | +8.1% | 16,7 M € | -1.5% | 16,9 M € | -1.4% | 17,1 M € | -18.3% | 21,0 M € | +21.2% | 17,3 M € | +65.2% | 10,5 M € | +1.4% | 10,3 M € | +0.5% | 10,3 M € | -13.0% | 11,8 M € | +19.4% | 9,9 M € | -41.1% | 16,8 M € | +116.5% | 7,8 M € | +4.6% | 7,4 M € | -23.6% | 9,7 M € | +25.3% | 7,8 M € | |
| Profit/loss | 60,8 M € | -24.5% | 80,5 M € | -11.9% | 91,4 M € | +348.6% | 20,4 M € | +3.9% | 19,6 M € | +17.2% | 16,7 M € | +18.4% | 14,1 M € | +257.3% | 4,0 M € | -42.9% | 6,9 M € | -54.1% | 15,1 M € | +65.6% | 9,1 M € | -15.2% | 10,7 M € | +14.8% | 9,4 M € | +432.2% | 1,8 M € | -48.6% | 3,4 M € | -7.4% | 3,7 M € | +390.1% | -1,3 M € | |
| Equity | 456,8 M € | +15.4% | 396,0 M € | +25.5% | 315,4 M € | +19.5% | 264,0 M € | +8.4% | 243,7 M € | +8.8% | 224,0 M € | +8.1% | 207,3 M € | +7.3% | 193,2 M € | +30.3% | 148,2 M € | +49.3% | 99,3 M € | +17.9% | 84,2 M € | +12.1% | 75,1 M € | +16.7% | 64,3 M € | +51.6% | 42,4 M € | +4.3% | 40,7 M € | +9.2% | 37,2 M € | +11.0% | 33,5 M € | |
| Total assets | 538,7 M € | +14.0% | 472,7 M € | +19.9% | 394,1 M € | +19.5% | 329,6 M € | +8.7% | 303,1 M € | +3.3% | 293,5 M € | +6.0% | 276,9 M € | +8.8% | 254,5 M € | +23.3% | 206,3 M € | +2.1% | 202,1 M € | +6.2% | 190,4 M € | -1.0% | 192,2 M € | +9.8% | 175,1 M € | +57.1% | 111,5 M € | -4.1% | 116,2 M € | +4.7% | 111,0 M € | -4.9% | 116,7 M € | |
| Cash | 19,9 M € | +28.3% | 15,5 M € | -41.6% | 26,6 M € | +95.9% | 13,6 M € | -22.8% | 17,6 M € | -35.0% | 27,0 M € | +159.3% | 10,4 M € | +70.0% | 6,1 M € | -24.2% | 8,1 M € | -27.5% | 11,2 M € | +80.8% | 6,2 M € | -35.8% | 9,6 M € | +23.4% | 7,8 M € | +108.5% | 3,7 M € | +21.0% | 3,1 M € | +10.0% | 2,8 M € | -32.3% | 4,1 M € | |
| Debts | 63,5 M € | +9.8% | 57,8 M € | -0.2% | 57,9 M € | +8.4% | 53,4 M € | +17.5% | 45,5 M € | -15.6% | 53,9 M € | -5.6% | 57,1 M € | +17.5% | 48,6 M € | +5.7% | 45,9 M € | -50.8% | 93,4 M € | -3.2% | 96,5 M € | -11.2% | 108,6 M € | +3.8% | 104,6 M € | +60.9% | 65,0 M € | -9.9% | 72,2 M € | +1.9% | 70,8 M € | -13.8% | 82,2 M € | |
| Staff | 260,6 | 255,3 | 259,6 | 248,7 | 253,7 | 262,3 | 273,2 | 271,6 | 268,9 | 269,6 | 268,8 | 268,2 | 206 | 168,4 | 160,7 | 164,8 | 164,1 | |||||||||||||||||
Public limited company · Zaventem · incorporated on 11/05/1973 · 260,6 ETP
Public limited company profitable and well capitalised. Cash position rising (+28.3%).
Solid counterparty for a standard engagement.
Terumo BCT Europe is a Public limited company incorporated in 1973. Its main activity is: Commerce de gros de produits pharmaceutiques et médicaux. Its registered office is in Zaventem. It employs on average 260,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette